Skip to content

Chromostrate Antithrombin III Assay

by Warner-Lambert Co.

510(k) K850412

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 5 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 5 Oct 2026. What this means

Regulatory status

as of registry sync 5 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK850412 Date8 May 1985ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 5 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Gen. Diag. Chromostrate Antithrombin III Assay
510(k) Number
FDA Product Code
JBQ
Device Class
Class II
Regulation
21 CFR Part 864.7060
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Chromostrate Antithrombin III Assay is an in vitro diagnostic device classified as an Antithrombin III Quantitation test. It quantifies antithrombin III, a plasma protein that regulates blood coagulation and whose deficiency is linked to thromboembolic disorders. The assay provides objective measurement of antithrombin III levels, aiding in the diagnosis and management of coagulation disorders.

This assay is intended for use in clinical laboratories under the direction of qualified personnel. Supplied as a single-use diagnostic reagent, it requires validation per standard laboratory protocols. The device carries an FDA 510(k) clearance (K850412) under product code JBQ, classified as a Class II medical device. Storage and handling must comply with manufacturer instructions to maintain assay integrity, though no specific sterility or MRI safety requirements are noted in regulatory records.

Other devices from Warner-Lambert Co.

See all devices from Warner-Lambert Co. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Chromostrate Antithrombin III Assay used for?

    This assay quantifies antithrombin III, a plasma protein that regulates blood coagulation. Low levels are associated with thromboembolic disorders, so the test helps diagnose and monitor coagulation-related conditions in patients.

  • Is the Chromostrate Antithrombin III Assay single-use or reusable?

    The assay is supplied as a single-use diagnostic reagent. Each kit is designed for one-time use to ensure accurate and reliable results, requiring validation per standard laboratory protocols before each run.

  • How should the Chromostrate Antithrombin III Assay be stored?

    Storage and handling must follow the manufacturer’s instructions to preserve assay integrity. While no specific sterility or MRI safety requirements are noted, proper conditions (e.g., temperature, humidity) are critical to maintain reagent stability and test validity.

  • Does the Chromostrate Antithrombin III Assay require special handling for sterility?

    The device is not labeled with sterility requirements in regulatory records, but standard laboratory practices for in vitro diagnostics should be followed. Since it’s a single-use reagent, contamination risks are mitigated by proper storage and usage protocols.

  • What regulatory clearance does the Chromostrate Antithrombin III Assay hold?

    The assay holds FDA 510(k) clearance (K850412) under product code JBQ, classified as a Class II medical device. This clearance confirms it is substantially equivalent to a predicate device for quantitating antithrombin III in clinical settings.